These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Recent developments of peptidomimetic HIV-1 protease inhibitors. Qiu X; Liu ZP Curr Med Chem; 2011; 18(29):4513-37. PubMed ID: 21864279 [TBL] [Abstract][Full Text] [Related]
3. Identification of efficiently cleaved substrates for HIV-1 protease using a phage display library and use in inhibitor development. Beck ZQ; Hervio L; Dawson PE; Elder JH; Madison EL Virology; 2000 Sep; 274(2):391-401. PubMed ID: 10964781 [TBL] [Abstract][Full Text] [Related]
4. Resilience to resistance of HIV-1 protease inhibitors: profile of darunavir. Lefebvre E; Schiffer CA AIDS Rev; 2008; 10(3):131-42. PubMed ID: 18820715 [TBL] [Abstract][Full Text] [Related]
5. Design of symmetry-based, peptidomimetic inhibitors of human immunodeficiency virus protease. Kempf DJ Methods Enzymol; 1994; 241():334-54. PubMed ID: 7854187 [No Abstract] [Full Text] [Related]
6. Using Hierarchical Virtual Screening To Combat Drug Resistance of the HIV-1 Protease. Li N; Ainsworth RI; Ding B; Hou T; Wang W J Chem Inf Model; 2015 Jul; 55(7):1400-12. PubMed ID: 25993532 [TBL] [Abstract][Full Text] [Related]
7. A novel substrate-based HIV-1 protease inhibitor drug resistance mechanism. Nijhuis M; van Maarseveen NM; Lastere S; Schipper P; Coakley E; Glass B; Rovenska M; de Jong D; Chappey C; Goedegebuure IW; Heilek-Snyder G; Dulude D; Cammack N; Brakier-Gingras L; Konvalinka J; Parkin N; Kräusslich HG; Brun-Vezinet F; Boucher CA PLoS Med; 2007 Jan; 4(1):e36. PubMed ID: 17227139 [TBL] [Abstract][Full Text] [Related]
8. Crucial amides for dimerization inhibitors of HIV-1 protease. Bowman MJ; Chmielewski J Bioorg Med Chem Lett; 2004 Mar; 14(6):1395-8. PubMed ID: 15006369 [TBL] [Abstract][Full Text] [Related]